Dr. Raviraj Pillai
Chief Scientific Officer
A PhD in Chemical Engineering from the University of Illinois at Chicago, Ravi brings with him over 25 years of rich and diverse pharmaceutical R&D experience in generics (prescription and OTC), branded generics, speciality drugs and New Chemical Entities.
In his last role, Ravi was Senior Director and Head of Innovation and Development (I&D) within the Established Pharmaceuticals Division (EPD) at Abbott Healthcare Pvt. Ltd. He has previously been associated with Dr. Reddy’s, Perrigo, GlaxoSmithKline
and other pharma majors in India and the United States. In various leadership roles, Ravi has overseen work across dosage forms such as oral solids, liquids, soft gel, injectables, topical and transdermal patches. Ravi has a strong demonstrable
record in building and scaling up R&D, managing development internally, forging partnerships, driving strategy and execution through insights, innovation and multi-disciplinary groups. Ravi has to his name over 25 research publications and over
20 patents/patent filings in formulation development, drug delivery systems, platforms technologies, and Quality by Design.